Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Ivy

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Oncology (Williston Park, N.Y.)|February 24, 2001
NCI cooperative research and development agreementsS P Ivy
Oncology (Williston Park, N.Y.)|September 28, 1999
Clinical trials referral resource. Clinical trials of combination regimens containing oxaliplatinS P Ivy, G Blatner, B D Cheson
Oncology (Williston Park, N.Y.)|August 12, 1999
Clinical trials referral resource. Clinical trials of single-agent oxaliplatinS P Ivy, G Blatner, B D Cheson
Oncology (Williston Park, N.Y.)|June 5, 1999
Clinical trials referral resource. Clinical trials with gadolinium-texaphyrin and lutetium-texaphyrinS P Ivy, G Blatner, B D Cheson
Case Reports in Pediatrics|July 26, 2021
The Unusual Journey of a Pericardial Drainage Catheter in Pentalogy of CantrellMargaret P Ivy, Gareth J Morgan, Jenny E Zablah
Leukemia Research|October 31, 2001
Detection of P-glycoprotein in cell lines and leukemic blasts: failure of select monoclonal antibodies to detect clinically significant Pgp levels in primary cellsB J Taylor, D P Olson, S P Ivy
Cytometry|April 20, 2001
Detection of MRP functional activity: calcein AM but not BCECF AM as a Multidrug Resistance-related Protein (MRP1) substrateD P Olson, B J Taylor, S P Ivy
Pediatric Infectious Disease|March 1, 1984
Plesiomonas: biology of the organism and diseases in childrenD McNeeley, P Ivy, J C Craft, et al.
Cancer Chemotherapy and Biological Response Modifiers|May 9, 2000
Multidrug resistanceE Schneider, D Paul, P Ivy, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1997
Multidrug resistanceJ A Moscow, E Schneider, S P Ivy, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Oncology (Williston Park, N.Y.)|February 24, 2001
NCI cooperative research and development agreementsS P Ivy
Oncology (Williston Park, N.Y.)|September 28, 1999
Clinical trials referral resource. Clinical trials of combination regimens containing oxaliplatinS P Ivy, G Blatner, B D Cheson
Oncology (Williston Park, N.Y.)|August 12, 1999
Clinical trials referral resource. Clinical trials of single-agent oxaliplatinS P Ivy, G Blatner, B D Cheson
Oncology (Williston Park, N.Y.)|June 5, 1999
Clinical trials referral resource. Clinical trials with gadolinium-texaphyrin and lutetium-texaphyrinS P Ivy, G Blatner, B D Cheson
Case Reports in Pediatrics|July 26, 2021
The Unusual Journey of a Pericardial Drainage Catheter in Pentalogy of CantrellMargaret P Ivy, Gareth J Morgan, Jenny E Zablah
Leukemia Research|October 31, 2001
Detection of P-glycoprotein in cell lines and leukemic blasts: failure of select monoclonal antibodies to detect clinically significant Pgp levels in primary cellsB J Taylor, D P Olson, S P Ivy
Cytometry|April 20, 2001
Detection of MRP functional activity: calcein AM but not BCECF AM as a Multidrug Resistance-related Protein (MRP1) substrateD P Olson, B J Taylor, S P Ivy
Pediatric Infectious Disease|March 1, 1984
Plesiomonas: biology of the organism and diseases in childrenD McNeeley, P Ivy, J C Craft, et al.
Cancer Chemotherapy and Biological Response Modifiers|May 9, 2000
Multidrug resistanceE Schneider, D Paul, P Ivy, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1997
Multidrug resistanceJ A Moscow, E Schneider, S P Ivy, et al.
Pageof 4